The stock of Allergan Plc (NYSE:AGN) registered an increase of 12.76% in short interest. AGN’s total short interest was 6.63 million shares in September as published by FINRA. Its up 12.76% from 5.88 million shares, reported previously. With 3.00M shares average volume, it will take short sellers 2 days to cover their AGN’s short positions. The short interest to Allergan Plc’s float is 1.81%. About 1.89M shares traded hands. Allergan plc Ordinary Shares (NYSE:AGN) has declined 9.79% since February 8, 2016 and is downtrending. It has underperformed by 26.28% the S&P500.
The institutional sentiment decreased to 0.46 in 2016 Q2. Its down 0.29, from 0.75 in 2016Q1. The ratio worsened, as 11 funds sold all Allergan plc Ordinary Shares shares owned while 2 reduced positions. 3 funds bought stakes while 3 increased positions. They now own 58,328 shares or 8.83% less from 63,978 shares in 2016Q1.
Mengis Capital Management Inc. holds 1.27% of its portfolio in Allergan plc Ordinary Shares for 6,210 shares. Frontier Investment Mgmt Co owns 32,758 shares or 0.94% of their US portfolio. Moreover, Mitchell Mcleod Pugh & Williams Inc has 0.83% invested in the company for 3,975 shares. The California-based Grassi Investment Management has invested 0.22% in the stock. Armstrong Henry H Associates Inc, a Pennsylvania-based fund reported 3,690 shares.
Out of 15 analysts covering Allergan (NYSE:AGN), 12 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 80% are positive. Allergan has been the topic of 30 analyst reports since September 21, 2015 according to StockzIntelligence Inc. Mizuho upgraded the stock on August 19 to “Buy” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.